The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global peritoneal dialysis market size reached US$ 15.62 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 21.26 Billion by 2027, exhibiting a growth rate (CAGR) of 5.12% during 2022-2027.
Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual’s body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.
The increasing prevalence of hypertension, diabetes, and end-stage renal disease (ESRD), the rising shortages of kidney donors, and the emerging awareness amongst consumers regarding the risks associated with kidney transplants are majorly driving the market growth. Moreover, the growing need for home dialysis treatments, especially during the COVID-19 pandemic, is acting as another growth-inducing factor. Furthermore, the advent of various technologies, such as automated peritoneal dialysis (APD), to perform renal replacement therapy for patients and multiple exchanges at night is contributing to the market growth. Such advanced products aid in lowering the incidences of peritonitis and hernias and offer better small solute clearances, especially to the geriatric population facing chronic kidney disease (CKD). Additionally, the shifting inclination of health practitioners toward PD over haemodialysis as it ensures greater patient mobility at cost-effective prices while creating fewer symptom fluctuations is propelling the market growth. Apart from this, extensive investments in research and development activities (R&D) by governments, improving reimbursement policies, and the ongoing product diversification are positively stimulating the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global peritoneal dialysis market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment type, product and end user.
Breakup by Treatment Type:
Breakup by Product:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amecath, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medical Components Inc., Medionics International Inc., Medtronic plc, Merit Medical Systems Inc., Mitra Industries Pvt. Ltd., Newsol Technologies Inc., Nipro Canada (Nipro Medical Corporation), Poly Medicure Limited, Terumo Corporation and Utah Medical Products Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Treatment Type, Product, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Amecath, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medical Components Inc., Medionics International Inc., Medtronic plc, Merit Medical Systems Inc., Mitra Industries Pvt. Ltd., Newsol Technologies Inc., Nipro Canada (Nipro Medical Corporation), Poly Medicure Limited, Terumo Corporation and Utah Medical Products Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at